CoChat

Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis

Open access
Ricciardiello, Francesca, Votta, Giuseppina, Palorini, Roberta, Raccagni, Isabella, Brunelli, Laura, Paiotta, Alice, Tinelli, Francesca, D’Orazio, Giuseppe, Valtorta, Silvia, De Gioia, Luca, Pastorelli, Roberta, Moresco, Rosa Maria, La Ferla, Barbara, Chiaradonna, Ferdinando · 2018 · Cell Death & Disease
Cited by 91

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Cancer aberrant N- and O-linked protein glycosylation, frequently resulting from an augmented flux through the Hexosamine Biosynthetic Pathway (HBP), play different roles in tumor progression. However, the low specificity and toxicity of the existing HBP inhibitors prevented their use for cancer treatment. Here we report the preclinical evaluation of FR054, a novel inhibitor of the HBP enzyme PGM3, with a remarkable anti-breast cancer effect. In fact, FR054 induces in different breast cancer cells a dramatic decrease in cell proliferation and survival. In particular, in a model of Triple Negative Breast Cancer (TNBC) cells, MDA-MB-231, we show that these effects are correlated to FR054-dependent reduction of both N- and O-glycosylation level that cause also a strong reduction of cancer cell adhesion and migration. Moreover we show that impaired survival of cancer cells upon FR054 treatment is associated with the activation of the Unfolded Protein Response (UPR) and accumulation of intracellular ROS. Finally, we show that FR054 suppresses cancer growth in MDA-MB-231 xenograft mice, supporting the advantage of targeting HBP for therapeutic purpose and encouraging further investigation about the use of this small molecule as a promising compound for breast cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-0405-4

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 91

Metadata

Authors
Ricciardiello, F., Votta, G., Palorini, R., Raccagni, I., Brunelli, L., Paiotta, A., Tinelli, F., D’Orazio, G., Valtorta, S., De Gioia, L., Pastorelli, R., Moresco, R. M., La Ferla, B., & Chiaradonna, F.
Venue
Cell Death & Disease
Published
2018-03-07
Volume
9
Issue
3
Pages
377-377
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2895610217
Cited by
91
References
10
FWCI
3.14
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis. https://app.cochat.ai/papers/10.1038/s41419-018-0405-4
The paper
Ricciardiello, F., Votta, G., Palorini, R., Raccagni, I., Brunelli, L., Paiotta, A., Tinelli, F., D’Orazio, G., Valtorta, S., De Gioia, L., Pastorelli, R., Moresco, R. M., La Ferla, B., & Chiaradonna, F. (2018). Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis. Cell Death & Disease. https://doi.org/10.1038/s41419-018-0405-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.